About Genedesign
Genedesign is a Healthcare company based in Japan founded in 2000, and was acquired by Ajinomoto OmniChem in December 2016. Nucleic acid development and manufacturing services are provided. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.
Company details
Genedesign was founded in 2000 and is based in Ibaraki, Japan, within the biotechnology sector. Nucleic acids for therapeutics and diagnostics are manufactured by the company. Custom synthesis services encompass DNA, RNA, BNA, siRNA, in vivo grade products, and GMP-compliant production. Solid-phase synthesis methods are employed, supporting high-mix, low-volume operations. Acquisition by Ajinomoto and its subsidiary Ajinomoto OmniChem took place in December 2016.
- Headquarters Ibaraki, Japan
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website genedesign.co.jp
- Acquired by Ajinomoto OmniChem (Dec 2016)
- InvestorsAjinomoto
& 1 more
- Acquired byAjinomoto OmniChem
(Dec 2016)
Investors in Genedesign
Genedesign has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Ajinomoto and Ajinomoto OmniChem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-category food and beverage products are manufactured globally. | 1909 | ajinomoto.com | Tokyo, Japan | |
Global supplier of pharmaceutical APIs, fine chemicals, and sustainable products. | 1980 | ajinomoto-omnichem.com | Wetteren, Belgium |
Investor details for Genedesign
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genedesign
2 dated milestones of Genedesign across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Genedesign is founded.
- Exit Acquired by Ajinomoto OmniChem.
Web traffic of Genedesign
Websites that share an audience with Genedesign (genedesign.co.jp).
Websites whose visitors overlap most with Genedesign. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hssnet.co.jp | 100% | #1,338,115 | View details | ||
| cosmobio.co.jp | 84% | 130.8K | View details | ||
bioserentach.co.jp | bioserentach.co.jp | 84% | #14,565,753 | – | |
| cyclex.co.jp | 84% | View details | |||
alsi-i.co.jp | alsi-i.co.jp | 84% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Genedesign
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genedesign
Complete news archive for Genedesign
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genedesign
Genedesign was founded in 2000.
Genedesign is headquartered in Japan. It is registered at Ibaraki, Japan.
Genedesign was founded in 2000 and is based in Ibaraki, Japan, within the biotechnology sector. Nucleic acids for therapeutics and diagnostics are manufactured by the company. Custom synthesis services encompass DNA, RNA, BNA, siRNA, in vivo grade products, and GMP-compliant production. Solid-phase synthesis methods are employed, supporting high-mix, low-volume operations. Acquisition by Ajinomoto and its subsidiary Ajinomoto OmniChem took place in December 2016.
Genedesign has 2 investors. Key investors include Ajinomoto, and Ajinomoto OmniChem.
Yes. Genedesign was acquired by Ajinomoto OmniChem in December 2016.